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It is well known that neutrophils are rapidly recruited to a site of injury or infection and
perform a critical role in pathogen clearance and inflammation. However, they are also
able to interact with and regulate innate and adaptive immune cells and some stimuli
induce the migration of neutrophils to lymph nodes (LNs). Previously, we demonstrated
that the immune complex (IC) generated by injecting OVA into the footpad of OVA/CFA
immunized mice induced the migration of OVA+ neutrophils to draining LNs (dLNs).
Here we investigate the effects of these neutrophils which reach dLNs on CD4+ T cell
response. Our findings here strongly support a dual role for neutrophils in dLNs regarding
CD4+ T cell response modulation. On the one hand, the CD4+ T cell population expands
after the influx of OVA+ neutrophils to dLNs. These CD4+ T cells enlarge their proliferative
response, activation markers and IL-17 and IFN-γ cytokine production. On the other
hand, these neutrophils also restrict CD4+ T cell expansion. The neutrophils in the dLNs
upregulate PD-L1 molecules and are capable of suppressing CD4+ T cell proliferation.
These results indicate that neutrophils migration to dLNs have an important role in the
homeostasis of adaptive immunity. This report describes for the first time that the influx
of neutrophils to dLNs dependent on IC presence improves CD4+ T cell response, at the
same time controlling CD4+ T cell proliferation through a PD-L1 dependent mechanism.
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INTRODUCTION
Neutrophils are critical effector cells of the innate immune system and rapidly respond to tissue
injury and infection. The main role of neutrophils in an inflammatory immune response has been
associated with the elimination of pathogens by phagocytosis, the generation of reactive oxygen
species, the formation of extracellular traps, and the release of granule enzymes, and inflammatory
mediators (1, 2).
However, there is increasing evidence that neutrophils are versatile cells with the ability to interact
with different cells, from not only the innate but also the adaptive immune system (3, 4). It has
been reported that neutrophils can directly or indirectly modulate lymphocyte functions (5). The
regulatory mechanisms of neutrophils induce the functional maturation of B cells (6, 7) and the
regulation of T cell activation (8).
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Neutrophils can affect CD4+ T cell response directly by
releasing soluble mediators that regulate their priming (9).
They also induce the activation of dendritic cells (DCs) and
thus indirectly contribute to the subsequent T cell response
(10, 11). Other studies revealed that they are able to act as
antigen-presenting cells (APCs) (12, 13), and that neutrophils
can suppress CD4+ T cell response by secreting IL-10 (14, 15),
inhibiting DC functions (16), and through the expression of
programmed death ligand 1 (PD-L1) (17–19).
Neutrophils have the capacity to migrate to lymph nodes
(LNs) in response to different stimuli (20). Indeed, we previously
reported that the injection of ovalbumin (OVA) into the
footpad of previously OVA/Complete Freund’s adjuvant (CFA)-
immunized mice generates the formation of immune complexes
(IC), and as a consequence the main OVA+ cells in footpads
and draining popliteal LNs are neutrophils (21). We also showed
that neutrophils can enter LNs of OVA/CFA immunized mice
not only via lymphatic vessels but also from blood across high
endothelial venules, and we identified the homing molecules
required for their trafficking into LNs (22). With all this in mind,
we hypothesized that those neutrophils must be involved in the
modulation of the adaptive immune response in LNs.
The aim of this work was to evaluate the impact of neutrophils
which reach dLNs on CD4+ T cell response in immunized mice
after OVA footpad challenged. The data presented show that
the influx of OVA+ neutrophils to LNs induced CD4+ T cell
activation and proliferation and the production of IL-17 and IFN-
γ cytokines. We also found that these neutrophils express PD-L1
and restrict CD4+ T cell proliferation. Our results establish that
neutrophils have an important role in the homeostasis of adaptive
immunity in LNs, promoting the activation, and expansion of
CD4+ T cells but also controlling the CD4+ T cell response.
MATERIALS AND METHODS
Mice and Treatment
Wild-type (WT) C57BL/6 mice were purchased from the
Fundación Facultad de Ciencias Veterinarias (Universidad
Nacional de La Plata, La Plata, Argentina). PD-L1−/− mice
were provided by Dr. Halina Offner (Oregon Health and
Science University, Portland, OR, USA). OT-II mice, which
express a transgenic TCR designed to recognize OVA residues
323–339 in the context of H-2 I-Ab (23), were provided
by Dr. F.A. Goldbaum (Fundación Instituto Leloir, Buenos
Aires, Argentina). Mice were maintained in our animal facility
until use, following the standards of the Guide to the Care
and Use of Experimental Animals published by the Canadian
Council on Animal Care, with the assurance number A5802–
01 assigned by the Office of Laboratory Animal Welfare (NIH).
Our Institutional Animal Experimentation Committee approved
Abbreviations: DCs, dendritic cells; APCs, antigen presenting cells; PD-L1,
programmed death ligand 1; LNs, lymph nodes; OVA, ovalbumin; CFA, complete
freund’s adjuvant; IC, immune complexes; WT, wild-type; IFA, incomplete freund’s
adjuvant; SS, saline solution; BM, bone marrow; KO, knock out; dLNs, draining
popliteal lymph nodes; ndLNs, non-draining lymph nodes.
the animal handling and experimental procedures (Approval
Numbers 834/2015 and 746/2018).
Female 8 to 10-week-old mice were subcutaneously
immunized with 60 µg OVA (Fraction V; Sigma Aldrich)
emulsified in CFA (Sigma Aldrich) and 15 days later with 60 µg
OVA emulsified in Incomplete Freund’s adjuvant (IFA) (Sigma
Aldrich). Each animal was immunized with an entire dose (0.5
ml/animal/dose) distributed at three sites in the back region. Ten
days after the second immunization, mice were injected in the
hind footpad with 30 µg OVA, or 30 µg OVA conjugated with
FITC, following a previously described protocol (24), or 6 × 106
IC-stimulated purified neutrophils or with saline solution (SS) as
control.
Specific Antibody Detection Assay
Specific antibodies against OVA were determined by ELISA
following a previously described protocol (25). Briefly, 96-well
flat-bottom plates were coated with OVA (1 µg/well) and later
were incubated with serial dilutions of mice plasma. HRP-
conjugated anti-mouse polyclonal IgG (Sigma Aldrich), IgG1
(X56) and IgG2a/c (R19-15) (both from Becton Dickinson)
were used as detection antibodies. Titers were calculated as the
reciprocal of the last plasma dilution that yielded an absorbance
at 490 nm above that of twice the mean value of blank.
Cells Preparation and Flow Cytometry
Three to 56 h after footpad injection, mice were sacrificed,
and blood, bone marrow (BM), and LNs were removed to
obtained single-cell suspensions. Red blood cells were lysed using
RBC lysing buffer (Sigma Aldrich). For surface staining, cells
were pre-incubated with anti-CD16/36 (2.4G2) for 15min at
4◦C, and then stained for 30min at 4◦C with the following
fluorochrome-labeled antibodies: anti-mouse Ly6G (1A8), CD4
(RM4-5), CD62L (MEL14), CD11b (M1/70), PD-L1 (MIH5), and
TCR Vβ 5.1/5.2 (MR9-4) from BD Bioscience; anti-mouse CD3
(145-2C11), CD11c (N418), CD44(IM7), and CD69 (HI.2F3)
from eBioscience. For intracellular detection of cytokines, LN
cells (106 cell/well) were incubated with 0.65 µl/ml StopGolgi
Monensin (BD Biosciences) at 37◦C for 4 h. Then, cells were
stained for surface markers before being fixed and permeabilized
using the BD Cytofix/CytopermTM Plus Kit (BD Biosciences)
following the manufacturer’s instructions. Finally, cells were
stained with fluorochrome-labeled anti-mouse TNF (MP6-
XT22), IL-17 (11B7), IFN-γ (XMG1.2), or isotype-matched
control antibody (all from eBioscience) for 30min at 4◦C. For
intracellular staining of Ki67, LN cells (106 cell/well) were
stained for surface markers, then fixed and permeabilized with
the Transcription Factor Staining Buffer Set (eBioscience) in
accordance with the manufacturer’s instructions. Then cells were
stained with fluorochrome-labeled anti-mouse Ki67 (SolA15)
from eBioscience for 30min at 4◦C. In all cytometry assays,
fixable viability dye (eBioscience) was used to identify live cells.
Data acquisition was performed on a FACS II cytometer (BD
Bioscience) and analyzed using FlowJo software (Tree Star Inc.,
Ashland OR).
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Lymph Nodes Cells Culture
Cell suspensions obtained from LNs were cultured in GIBCO R©
RPMI 1640 medium (Life Technologies) supplemented with
10% heat-inactivated fetal bovine serum (NATOCOR), 2mm
GIBCO R© Glutamax, 100 U/ml Penicillin with 100µg/ml
Streptomycin (both from Life Technologies) and 50µm 2-
mercaptoethanol (Sigma Aldrich) at 37◦C in a 5% CO2
humidified incubator.When indicated, cells were stimulated with
100µg/ml OVA, 50 ng/ml PMA with 1,000 ng/ml Ionomycin
(Sigma Aldrich) or medium alone for 72 h.
Cytokine Determination
Levels of IFN-γ and IL-17 were measured in culture supernatants
by standard sandwich ELISA following the manufacturer’s
instructions (BD Biosciences). These antibodies were used for
coating and detection, respectively: R4-6A2 and XMG1.2 clones
for anti-IFN-γ (BD Biosciences), 17CK15A5 and 17B7 clones
for anti-IL-17 (eBioscience). The concentrations were expressed
in relation to standard curves constructed by assaying serial
dilutions of respective murine standard cytokines.
Proliferation Assay
For proliferation assays, 2.5 × 105 CD4+ T cells purified from
spleen of untreated OT-II mice were labeled with CFSE dye and
co-cultured with 2.5 × 105 LNs cells obtained from immunized
mice 6 h after footpad injection. After 72 h of culture with
medium alone or 200–400µg/ml OVA, cells were stained with
anti-mouse CD3 (145-2C11), CD4 (RM4-5), Vαβ (MR9-4), and
Ki67 (SolA15). The percentage of OT-II CD4+ T cell proliferation
was determined by CFSE dilution and Ki67 expression by flow
cytometry analysis.
Cell Purification
Neutrophils were isolated from BM and LNs with magnetic
microbeads following the manufacturer’s instructions (Miltenyi
Biotec). A single cell suspension was incubated with MACS
anti-Ly6G-biotin plus anti-biotin magnetic microbeads (Miltenyi
Biotec). Ly6G+ cell purity was > 95% as assessed by flow
cytometry.
CD4+ T cell purification was performed from a single cell
suspension of splenocytes from OT-II mice treated with RBC
lysing buffer. Cells were incubated with fluorochrome-labeled
anti-CD4 (RM4-5) for 30min at 4◦C, washed with MACS buffer
and isolated using cell sorting on a FACSAria II cell sorter (BD
Biosciences). The purity of sorted cells was always >98%.
Neutrophil Depletion in vivo
For neutrophil depletion, immunized mice were treated with
a monoclonal antibody purified from NIMP-R14 hybridoma,
which was provided by Dr. Geneviève Milon and Dr. Salah
Mecheri (Institut Pasteur, Paris, France). Total serum IgG from
rat was used as isotype control. First, 150 µg of antibody were
intraperitoneally administered 24 h before footpad injection,
then 75 µg of antibody was injected daily until the animals were
sacrificed.
IC Incubation and Adoptive Transfer
Purified neutrophils from BM of WT or PD-L1 Knock-out (KO)
mice were incubated for 1 h at 37◦C in a 5% CO2 humidified
incubator with previously formed OVA/anti-OVA IC (1,25× 106
cel/ml of IC). The IC were formed by incubation of inactivated
polyclonal anti-OVA rabbit sera (dilution 1/75) (NATOCOR)
with OVA to a final concentration of 1.6µg/ml for 30min
at 37◦C. Then, 6 × 106 IC-incubated neutrophils or SS were
injected into the footpad of WT immunized mice 10 days
after OVA/IFA booster immunization and, 36 h later, popliteal
LNs were surgically removed and single cell suspensions were
prepared for analysis by Flow Cytometry.
Statistical Analysis
Results are expressed as the mean ± SEM. Data were analyzed
using GraphPad Prism software. Data analysis included the
unpaired Student t test, one-way ANOVA, and two-way ANOVA
followed by a Bonferroni post-hoc test. All data were considered
statistically significant for p < 0.05.
RESULTS
Transient Influx of OVA+ Neutrophils to
LNs of OVA/CFA + OVA/IFA Immunized
Mice After OVA Footpad Injection
The formation of IC required to induce neutrophil migration
to LNs was performed by the following experimental
approach. First, C57BL/6 mice received one immunization
of OVA/CFA and 15 days later were boosted with OVA/IFA.
To evaluate the arrival of neutrophils in LNs, 10 days after
the last immunization the mice were injected with OVA-
FITC into the hind footpad and draining popliteal lymph
nodes (dLNs) were obtained at different time points. As a
control, SS footpad injections were made and the popliteal
LNs obtained were named non-draining lymph nodes
(ndLNs).
LN cells from immunized mice were analyzed by flow
cytometry to identify OVA+ neutrophils by their high expression
of the Ly6G marker and the presence of OVA-FITC. As shown in
Figure 1A, 6 h after footpad injection, OVA+ neutrophils arrived
exclusively in dLNs and were absent in ndLNs.
The arrival of OVA+ neutrophils in dLNs happened
together with OVA-specific antibodies in plasma. We found
elevated levels of total IgG, IgG1 and IgG2c OVA-antibody
in plasma from immunized mice 10 days after OVA/IFA
booster immunization (Figure 1B). Besides, neutrophils in
dLNs exhibited a positive cytoplasmic staining for TNF
(Figure 1C).
We next studied the kinetics of neutrophil migration to
dLNs and evaluated how long these cells remain there. The
highest number of OVA+ neutrophils in dLNs was detected
6 h after OVA injection and, at 12 h, the number of these
cells had decreased, reaching basal levels (Figure 1D). This
matches the kinetics of total neutrophils, because the majority
of neutrophils were OVA+ (Supplementary Figure 1A). These
results showed that neutrophil influx to dLNs was rapid, as
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FIGURE 1 | Transient influx of OVA+ neutrophils to LNs of OVA/CFA + OVA/IFA immunized mice after OVA footpad injection. C57BL/6 mice were immunized at day 0
with OVA/CFA and at day 15 with OVA/IFA. Ten days after the second immunization, mice were injected in the hind footpad with OVA-FITC or SS as control to obtain
dLNs and ndLNs, respectively. (A) Flow cytometry analysis of Ly6Ghi OVA-FITC+ neutrophils in dLNs and ndLNs obtained 6 h after footpad injection. Representative
dot plots with numbers indicating percentage of cells and bar graph of the analysis. (B) OVA-specific total IgG, IgG1 and IgG2c titers from plasma obtained 10 days
after last immunization compared with unimmunized animals. (C) Representative dot plot of flow cytometry for intracellular staining of TNF on Ly6Ghi alive gated cells.
Numbers indicate the percentage of cells. dLNs cells obtained 6 h after OVA footpad injection were cultured in vitro without re-stimulation. (D) Absolute number of
Ly6Ghi OVA-FITC+ neutrophils in LNs obtained from immunized mice at different time points after footpad injection. In the dotted line, normal values of LNs from
unimmunized mice are shown as reference. Results are representative of three independent experiments and are expressed as mean ± SEM (n = 4/group);
*p < 0.05, ***p < 0.001, ****p < 0.0001.
they were found 3 h after OVA footpad injection, and transient,
because at 48 h no more were detected. In ndLNs, the number of
neutrophils and OVA+ neutrophils was insignificant at all times
studied.
Collectively, our data indicate that the injection of OVA into
the footpad of OVA/CFA+OVA/IFA-immunized mice that have
anti-OVA antibodies induces a transient migration of OVA+
neutrophils to dLNs that produce TNF.
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Neutrophil Influx to dLNs Induces CD4+ T
Cell Expansion
To study the impact of neutrophil recruitment to dLNs on
the other cell populations present there, we first examined the
total number of LN cells. As shown in Figure 2A, the total
number of cells in dLNs increased but, surprisingly, not when
the neutrophils were present but later at 24–48 h, indicating
that other cells were increasing in the dLNs after the neutrophil
influx.
It has been reported that neutrophils in LNs are able to
promote CD4+ T cell proliferation (26). We therefore decided
to study CD4+ T cells in dLNs and observed that, 48 h after
OVA footpad injection, their number increased, which matches
the time of the total increase of dLN cells (Figure 2B). We also
evaluated CD4+ T cell subsets and found that, at 48 h, there was
an increase of naïve, effectormemory, and central memory CD4+
T cells in dLNs, indicating a massive increase of this population
(Figure 2C).
In addition, 24 h after OVA injection, we observed an
increase of CD11c+ DCs in dLNs. However, when we
analyzed OVA+ DCs, the highest number of OVA+CD11c+
cells was observed 6 h after OVA footpad injection in dLNs
(Supplementary Figure 1B). As the number of OVA+ CD11c+
cells is at least ten times less than that of OVA+ Ly6Ghi cells,
it should be noted that the main antigen carrier cells were
neutrophils.
To evaluate whether the increase of CD4+ T cells observed
in dLNs was due to neutrophil arrival, immunized mice were
treated with NIMP-R14 antibody to deplete neutrophils in vivo.
The experimental approach used and the neutrophil depletion
controls are shown in (Supplementary Figures 2A–C). At 56 h
after OVA footpad injection, in neutrophil-depleted mice we
did not observe a significant increase of LN total cells or of
CD4+ T cells in dLNs, unlike the animals that received the
isotype control antibody (Figures 3A,B). Similar results were
observed when we analyzed naïve, effector memory and central
memory CD4+ T cell subsets (Figure 3C). Thus, the influx of
neutrophils induced the increase of CD4+ T cell populations
observed in dLNs from immunized mice after OVA footpad
injection.
These findings indicate that the presence of OVA+ neutrophils
in dLNs influences the CD4+ T cell population. Neutrophil influx
was necessary for CD4+ T cell expansion in dLNs.
CD4+ T Cell Activation and Proliferation Is
Induced in dLNs After OVA+ Neutrophil
Influx
As the number of CD4+ T cells increased in dLNs, we next
studied whether the presence of OVA+ neutrophils in LNs
subsequently affected the CD4+ T cell response in dLNs obtained
24 h after OVA footpad injection.
First, we examined the cytokines produced by CD4+ T cells
by flow cytometry analysis of LN cells stimulated in vitro, and
found that the percentages of IL-17+ CD4+ T cells and IFN-γ+
CD4+ T cells were significantly higher in dLNs than in ndLNs
(Figure 4A). No double positive IL-17+ IFN-γ+ CD4+ T cells
were detected (Supplementary Figure 3).
To evaluate whether CD4+ T cells from dLNs were
activated, we analyzed the expression of the cell surface
marker CD69. CD4+ T cells from dLNs had higher
levels of CD69 than those present in ndLNs, the levels of
which were similar to those of an unimmunized mouse
(Figure 4B).
Then we wondered if the CD4+ T cells that were more
activated in dLNs were also proliferating, and therefore
we performed flow cytometry analysis of Ki67 levels.
CD4+ T cells from dLNs showed a higher percentage of
Ki67 levels, indicating augmented proliferative response
(Figure 4C).
Finally, to evaluate if the increase of CD4+ T cell cytokine
production was antigen-specific, LN cells were stimulated in vitro
with OVA for 72 h. As shown in Figure 4D, we found increased
IL-17 and IFN-γ levels in the culture supernatant from dLNs,
while IL-5 and IL-4 concentrations were not detected (data not
shown).
These results demonstrate that, after the migration wave of
OVA+ neutrophils in dLNs, CD4+ T cells proliferate and also
upregulate CD69 and produce IL-17 and IFN-γ, which indicates
that they are more activated.
Neutrophils in dLNs Enhance CD4+ T Cell
Proliferation
Considering that an increased number of proliferating CD4+
T cells was observed in dLNs, we decided to evaluate whether
the influx of neutrophils impacts CD4+ T cell proliferation.
We performed flow cytometry analysis of neutrophil-depleted
mice to study proliferating Ki67+ CD4+ T cells in LNs 56 h
after OVA footpad injection. As shown in Figure 5A, neutrophil-
depleted mice did not have a significant increase of percentage
or absolute number of Ki67+ CD4+ T cells in dLNs compared
to ndLNs.
To corroborate that neutrophils which migrate to dLNs were
required to increase CD4+ T cell proliferation, adoptive transfer
experiments were performed. First, neutrophils purified fromBM
were incubated in vitrowith previously formed IC. As control, we
observed that neutrophils upregulated their CD11b levels after IC
incubation (Supplementary Figure 4). Then, these neutrophils
were transferred to the footpads of immunized mice 10 days after
OVA/IFA booster immunization, instead of the OVA footpad
injection. In our previous work (22), we demonstrated that, with
this experimental strategy, neutrophils that were incubated with
IC reach dLNs mimicking what happens when IC is formed in
vivo. As shown in Figure 5B, the number of total cells, CD4+
T cells, and proliferative Ki67+ CD4+ T cells increased more in
LNs obtained from mice that were transferred with IC-incubated
neutrophils compared with LNs from mice that received the SS
injection.
These results show that neutrophils that reach dLNs after IC
incubation are essential to induce CD4+ T cell proliferation in
dLNs.
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FIGURE 2 | CD4+ T cells expansion after neutrophils influx to dLNs. Flow cytometry analysis of cell populations in dLNs and ndLNs obtained from immunized mice at
different time points after footpad injection. In the dotted line, normal values of LNs from unimmunized mice are shown as reference. Absolute number of (A) total
cells; (B) CD4+ T cells; (C) CD62L+CD44− naïve, CD62L− CD44+ effector memory, and CD62L+ CD44+ central memory CD4+ T cells. Results are representative
of three independent experiments and are expressed as mean ± SEM (n = 4/group); ns, not significant, *p < 0.05, **p < 0.001, ***p < 0.001.
FIGURE 3 | The increase of CD4+ T cells depends on the arrival of neutrophils to the LNs. Immunized mice were treated with isotype control or NIM-R14 antibody to
deplete neutrophils; dLNs and ndLNs were obtained 56 h after OVA or SS footpad injection. Absolute number of (A) total cells; (B) CD4+ T cells; (C) CD62L+CD44−
naïve, CD62L− CD44+ effector memory and CD62L+ CD44+ central memory CD4+ T cells were determined by flow cytometry. Results are representative of three
independent experiments and are expressed as mean ± SEM (n = 4–5/group); ns, not significant, *p < 0.05, **p < 0.001, ***p < 0.001, ****p < 0.0001.
CD4+ T Cell Proliferation Is Restricted
When Neutrophils Are Present in dLNs
The results above showed that CD4+ T cell proliferation
was enhanced in dLNs where IC-incubated neutrophils had
previously arrived. However, as shown in Figure 6A, when we
studied CD4+ T cell proliferation at different time points after
footpad injection, we observed that at 6 h there was no significant
difference of percentages of Ki67+ CD4+ T cells between ndLNs
and dLNs. In contrast, at longer time points there were higher
levels of Ki67+ CD4+ T cells in dLNs. Taking into account
that the higher number of OVA+ neutrophils in dLNs was
observed at 6 h after OVA footpad injection and that they were no
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FIGURE 4 | CD4+ T cell activation and proliferation is induced in dLNs after OVA+ neutrophil influx. dLNs and ndLNs cells were obtained from immunized mice 24 h
after OVA or SS footpad injection. (A) Cells were cultured for 72 h with PMA and Ionomycin or medium alone and later the percentage of IL-17+ CD4+ T cells and
IFN-γ+ CD4+ T cells was determined by flow cytometry analysis. (B) Geometric mean (Gmean) of CD69 levels in CD4
+ T cells. Unimmunized mice were used as
control. (C) Representative dot plot of Ki67+ CD4+ T cells with numbers indicating percentage of gated cells and bar graph of the analysis. (D) Cells were cultured for
72 h with OVA (100µg/mL) or medium alone to measure IL-17 and IFN-γ in the culture supernatant by ELISA; data represent stimulated minus unstimulated levels of
cytokines. Results are representative of three independent experiments and are expressed as mean ± SEM (n = 4–5/group); ns, not significant, *p < 0.05,
**p < 0.001, ***p < 0.001.
longer present from 12 h onwards, we decided to study whether
neutrophils were restricting CD4+ T cell proliferation.
Next, we decided to evaluate whether the neutrophils
present in dLNs obtained at 6 h after OVA footpad injection
could modulate OVA-specific naïve CD4+ T cells proliferative
response.We performed in vitro proliferation assays using CFSE-
labeled OVA-specific CD4+ T cells obtained from untreated OT-
II mice stimulated with OVA. These cells were co-cultured with
LN cells fromWT immunized mice obtained at 6 h after footpad
injection, to evaluate whether the presence of neutrophils in those
co-cultures inhibited OT-II CD4+ T cell proliferation. After 72 h
of culture, we observed that the proliferative response was lower
when OT-II CD4+ T cells were cultivated with dLNs than in
cells cultured with ndLNs cells (Figure 6B). This may indicate
that neutrophils present in dLNs were restricting CD4+ T cell
proliferation.
To confirm this, we next worked with dLN cells obtained from
immunized mice at 6 h after OVA footpad injection that were
depleted of neutrophils with magnetic beads (F-). As controls,
we also used total dLN cells and the neutrophils purified from
these (F+). These cells were co-cultured with CFSE-labeled OT-
II CD4+ T cells and stimulated in vitro with OVA. As expected,
in the co-culture in which neutrophils were absent, the OT-II
CD4+ T cell proliferative response was greater than in the co-
cultures with total dLN cells (Figure 6C). This indicated that
neutrophils present in dLNs were suppressing CD4+ T cell
proliferation. Although the lowest percentage of OT-II CD4+ T
cell proliferation was found when co-cultured with neutrophils
alone, this may be due not only to the inhibitory effect of
neutrophils but might also be attributed to the lack of APCs
required to mount a CD4+ T cell response.
These findings demonstrate that CD4+ T cell proliferation is
restricted when neutrophils are present in dLNs.
PD-L1+ Neutrophils in dLNs Impair CD4+ T
Cells Proliferation
PD-L1 is a transmembrane protein that binds to the receptor
PD-1 present in lymphocytes and transmits an inhibitory signal
that, among other functions, reduces the proliferation of T cells
(27). We next analyzed PD-L1 levels in neutrophils and observed
that the neutrophils present in dLNs had higher levels of PD-L1
than the few of them found in ndLNs obtained from immunized
mice 6 h after footpad injection (Figure 7A). Neutrophils from
BM and blood from immunized mice and from unimmunized
mice were used as controls, demonstrating that only neutrophils
that reached dLNs upregulate PD-L1.
To evaluate whether PD-L1+ neutrophils were restricting
the CD4+ T cell response in vivo, PD-L1 KO mice were
immunized and, 48 h after OVA footpad injection, we observed
a higher number of Ki67+ CD4+ T cells in dLNs than in
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FIGURE 5 | IC-incubated neutrophils enhance CD4+ T cell proliferation. (A) Percentage and absolute number of Ki67+ CD4+ T cells in dLNs and ndLNs obtained
56 h after OVA or SS footpad injection of immunized mice treated with isotype control or NIMP-R14 antibody to deplete neutrophils. (B) Neutrophils were purified from
BM and incubated in vitro with IC for adoptive transfer experiments. IC-incubated neutrophils or SS were transferred into the footpad of immunized mice 10 days after
OVA/IFA booster immunization; 36 h later the absolute number of LN total cells, CD4+ T cells, and Ki67+ CD4+ T cells was analyzed by flow cytometry. Results are
representative of three independent experiments and are expressed as mean ± SEM (n = 4–5/group); ns, not significant, *p < 0.05, **p < 0.001.
WT immunized mice (Figure 7B). We also performed adoptive
transfer experiments in which in vitro IC-incubated neutrophils
isolated from BM of WT or PD-L1 KO untreated mice were
transferred to the footpad of WT immunized mice. As shown in
Figure 7C, 36 h after adoptive transfer, the animals that received
PD-L1 KO neutrophils showed a higher number of total LN cells,
CD4+ T cells, and proliferative Ki67+ CD4+ T cells than those
that were transferred with WT neutrophils, whose numbers were
already higher than those that received SS. Thus, IC-incubated
neutrophil migration to LNs induces CD4+ T cell proliferation
and, at the same time, this proliferation is restricted by PD-L1.
Collectively, this data strongly supports a dual role for
neutrophils that reach dLNs in the modulation of CD4+ T cell
response. After the influx of neutrophils to LNs dependent on
IC formation, CD4+ T cells are more activated and proliferating
but also the expansion of CD4+ T cells is restricted by the PD-L1
molecule expressed by the neutrophils.
DISCUSSION
Neutrophils are recognized for performing a critical role in
pathogen clearance, inflammation, and wound healing (2) but
they also have the ability to interact and regulate other cells of the
immune system (4, 5, 28). Additionally, it has been reported that
there are different stimuli, like infection with bacteria (26, 29),
protozoan parasites (30, 31), viruses (32, 33), as well as the tumor
microenvironment (34), that generate neutrophil influx to the
LN, while under normal physiological conditions these cells are
absent in this organ. Our group was the first to demonstrate
that the formation of IC is a stimulus capable of inducing the
migration of neutrophils to LNs under inflammatory conditions
without ongoing infection (21).
The study of the effects of IC on neutrophils has great
relevance since IC-induced activation plays a central role in
the pathogenesis of some autoimmune inflammatory diseases
(35). It is well known that the synovial fluid of patients with
active Rheumatoid Arthritis contains large quantities of IC that
can activate infiltrating neutrophils (36). However, the role of
neutrophils that migrate to LNs in this scenario is little known.
Previously, we showed that immunized mice that have specific
antibodies, when challenged with the same antigen, generate the
IC formation necessary for the migration of neutrophils to LNs
(21, 22). In those studies, mice had received 3 immunizations
of OVA/CFA and then were challenged with OVA in their
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FIGURE 6 | CD4+ T cell proliferation is restricted when neutrophils are present in dLNs. (A) Percentage of Ki67+ CD4+ T cells determined by flow cytometry analysis
of dLNs and ndLNs cells obtained at 6, 24, and 48 h after immunized mice received OVA or SS footpad injection. (B,C) in vitro proliferation assay of CD4+ T cells
isolated from untreated OT-II mice and labeled with CFSE dye. These cells were co-cultured with the following cells obtained from immunized mice 6 h after footpad
injection: (B) dLNs or ndLNs; (C) dLNs, negative fraction (F-) that consists of dLNs without neutrophils or positive fraction (F+) of neutrophils purified from dLNs. After
72 h culture with medium alone, 200 or 400µg/ml OVA, cells were stained with anti-CD3, anti-CD4, anti-Vαβ, anti-Ki67, and percentage of OT-II CD4+ T cell
proliferation was determined by CFSE dilution and Ki67 expression. In (C) representative dot plots are also shown, with numbers indicating percentage of proliferating
gated cells and graph bars representing 400µg/ml OVA minus basal levels. Results are representative of three independent experiments and are expressed as mean
± SEM (n = 4/group); ns, not significant, **p < 0.001, ***p < 0.001, ****p < 0.0001.
footpad. In the present work we changed our immunization
protocol to reduce undesirable side effects of CFA that produce
skin ulceration (37, 38). The influx of OVA+ neutrophils
to LNs was induced even when we decreased the number
of immunizations and exchanged the CFA adjuvant for IFA
in the second immunization; IFA is the incomplete Freund’s
adjuvant form that lacks the mycobacterial components. Indeed,
the specific antibody production measured in this work was
consistent with the previous immunization model. Moreover,
neutrophil trafficking into LNs also occurred when neutrophils
were incubated with IC in vitro and then transferred to the
animal’s footpad.
Neutrophils are known to provide the first line of defense by
being quickly recruited at a site of injury, where they fulfill their
protection function and die within a few hours (2, 39). However,
it has been reported that some stimuli may increase the lifespan
of neutrophils (40). For this reason, we studied the kinetics of
neutrophils migration to dLNs and evaluated how long these cells
remain there. We observed that neutrophil influx to dLNs was
rapid, as they were found 3 h after OVA footpad injection, and
the highest number of OVA+ neutrophils in dLNs was detected at
6 h. Also, neutrophil influx to dLNs was transient, since 12 h after
OVA footpad injection the number of these cells had decreased
reaching basal levels and at 48 h no more were detected.
Many functions have been attributed to neutrophils that
reach the LNs, depending on the stimulus that induced the
migration, the microenvironment of the LNs, and the timing
(20). Previously, we observed by confocal microscopy that there
were neutrophils in the T-cell zone of dLNs 6 h after OVA footpad
injection (22), suggesting that there might be some crosstalk
between neutrophils and T lymphocytes. In this work, we have
shown that the number of CD4+ T cells increased in dLNs after
the influx of OVA+ neutrophils. We observed that the expansion
of CD4+ T cells is not exclusive to any particular subset, but
rather a massive expansion of this population occurred, since
there was an increase of naïve and effector memory CD4+ T
cells as well as of central memory CD4+ T cells responsible for
long-term protection. Contrary to our results, Hor et al. showed
that CD4+ T cell expansion and their levels of CD69, CD62L,
and CD44 molecules were unaffected after neutrophil influx to
LNs, in a mouse model of cutaneous herpes simplex virus type
1 (33). This suggests that the ability of neutrophils to induce
CD4+ T cell expansion may be context-dependent, and is likely
to be determined by the type of stimulus that induces neutrophil
migration to LNs.
In agreement with other authors (14, 31, 41), we found
that neutrophils were able to modulate adaptive immunity by
regulating T cell polarization. The CD4+ T cells obtained from
dLNs after the influx of neutrophils were more activated and
produced higher levels of IFN-γ and IL-17 cytokines than those
from ndLNs.
We also demonstrated that neutrophil migration to dLNs
enhances CD4+ T cell proliferation 24 to 56 h after OVA footpad
injection. The increase of Ki67+ CD4+ T cells depends on the
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FIGURE 7 | PD-L1+ neutrophils in dLNs impair CD4+ T cell proliferation. (A) Geometric mean (Gmean) of PD-L1 levels on Ly6G
hi neutrophils present in dLNs, ndLNs,
blood, and BM obtained from immunized mice 6 h after footpad injection; blood and BM cells from unimmunized mice were used as reference. Representative
histogram of PD-L1 levels on neutrophils from blood, dLNs, and ndLNs of immunized mice is also shown. (B) Absolute number of Ki67+ CD4+ T cells in dLNs and
ndLNs obtained from WT or PD-L1 KO immunized mice at 48 h after footpad injection. (C) For adoptive transfer experiments, neutrophils were purified from BM of WT
or PD-L1KO untreated mice and incubated in vitro with IC. IC-incubated neutrophils from WT or PD-L1KO mice or saline solution (SS) were transferred into the
footpad of WT immunized mice 10 days after OVA/IFA booster immunization; 36 h later, the absolute number of LN total cells, CD4+ T cells, and Ki67+ CD4+ T cells
was analyzed by flow cytometry. Results are representative of three independent experiments and are expressed as mean ± SEM (n = 4/group); ns, not significant,
*p < 0.05, **p < 0.001, ***p < 0.001, ****p < 0.0001.
arrival of neutrophils, since neutrophil-depleted mice showed
lower levels of proliferation. The adoptive transfer of in vitro IC-
incubated neutrophils also induced an increase of Ki67+ CD4+
T cells in LNs. In agreement with our results, it has been reported
that neutrophils promote CD4+ T cell proliferation in LNs
after immunization with killed Staphylococcus aureus (26). The
expansion of CD4+ T cells observed in dLNs is a consequence, at
least in a large extent, of CD4+ T cells proliferation, although we
cannot discard that the recruitment of these cells could also be
involved.
The neutrophils that reach dLNs in our experimental model
could be contributing to the activation and expansion of CD4+
T cells through different mechanisms. We demonstrated that
neutrophils perform the antigen (OVA) uptake and transport
from the footpad to the dLNs, where they reach antigen-specific
lymphocytes generated by immunization, as has been reported in
other studies in which neutrophils shuttle S. aureus particles (26)
and live bacilli of BCG (29) from skin to LNs.
It has also been shown that neutrophils could directly or
indirectly collaborate with antigen presentation to CD4+ T cells.
Several studies have reported that neutrophils can behave as
APCs (12, 42, 43), and indeed Hülsdünker et al. recently reported
that, at the onset of a graft-vs.-host disease, neutrophils migrate
to mesenteric LNs, and have the ability to present a peptide in
the context of MHC-II inducing CD4+ T cell proliferation (44).
Unlike this and other reports (26, 44), we did not observe elevated
levels of MHC-II or CD86 in neutrophils that reached dLNs (data
not shown). Actually, in our proliferative assay of OT-II CD4+
T cells co-cultivated with neutrophils purified from dLNs, we
observed that the proliferation of CD4+ T cells was abolished.We
consider that this result is due to the combination of suppression
exerted by the neutrophil and a lack of professional APCs
in the culture. Vono et al. reported that human neutrophils
can function as APCs to memory CD4+ T cells, although in
the expression of co-stimulatory molecules as well as in the
lymphocyte proliferative assay, neutrophils were less efficient
compared to professional APCs (13).
Alternatively, neutrophils may influence CD4+ T cell
responses indirectly by acting upon DCs (45). We previously
demonstrated that neutrophils die in dLNs by apoptosis (21) and
therefore a possible explanation of why we observed OVA+ DCs
in dLNs could be that neutrophils had died in dLNs, and their
cellular debris including OVA may be phagocytosed by DCs and
they then present the antigen to CD4+ T cells. However, further
experiments are needed to confirm this hypothesis. We cannot
exclude the possibility that DCs can uptake the antigen in the
footpad and then migrate to dLNs, nor that soluble OVA reaches
the LNs and then resident DCs uptake it. Although these last two
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options could be contributing to the activation and proliferation
of CD4+ T cells, we cannot underestimate the importance of
neutrophil influx to dLNs because the increase of Ki67+ CD4+
T cells was impaired in neutrophil depletion experiments.
Finally, we showed that neutrophils that reached dLNs are
TNF producers. It has been reported that TNF is a pleiotropic
cytokine synthesized by several cell types including activated
neutrophils and can cause the activation and expansion of CD4+
T cells (46). Therefore, the TNF produced by neutrophils in dLNs
could be contributing to the CD4+ T cell response observed.
Although we suggest that the ability of the neutrophil to
transport the antigen to LNs, to produce TNF and maybe
collaborate directly or indirectly to antigen presentation, may
cause the activation and expansion of CD4+ T cells, we do
not discard the possibility that other mechanisms may also be
contributing to these actions.
On the other hand, many reports have established that, in
certain contexts, neutrophils acquire inhibitory functions and
suppress CD4+ T cell (14, 15, 47). In our in vitro proliferation
assays, we observed that the presence of neutrophils restricts
CD4+ T cell antigen-specific proliferation. In this work, we
describe for the first time that neutrophils that reach dLNs
enhance the activation and expansion of CD4+ T cells and at
the same time restrict CD4+ T cell proliferation, probably as a
compensatory mechanism to avoid harmful excessive response.
Several mechanisms used by neutrophils for T cell inhibition
have been reported, including soluble mediators, and cell-to-cell
contact (5). We assessed the ability of neutrophils from dLNs to
produce nitric oxide as a suppressor mechanism and their levels
were undetectable (data not shown). Also, we evaluated if those
neutrophils were producing IL-10 and, although we observed
a small percentage of IL-10+ neutrophils by flow cytometry,
there were no significant differences in IL-10 levels of dLNs and
ndLNs culture supernatant, suggesting that this cytokine is not
implicated in neutrophil suppressive capacity (data not shown).
Interestingly, we found that only neutrophils that reach dLNs
upregulate PD-L1, a ligand that has been described as causing
the inhibition of CD4+ T cell proliferation (27). It has been
reported in human (17) and murine (19) endotoxemia that
IFN-γ-stimulated neutrophils acquired the capacity to suppress
lymphocyte proliferation through the expression of PD-L1. In
our model, 48 h after footpad injection with OVA, immunized
PD-L1KO mice showed a higher number of Ki67+ CD4+
T cells than WT immunized mice. In addition, the adoptive
transfer of IC-incubated PD-L1 KO neutrophils enhanced the
proliferation of CD4+ T cells even more than WT transferred
neutrophils, suggesting that PD-L1 expression on neutrophils
could be preventing an excessive CD4+ T cell proliferation.
Two general features of our in vivomodel are the generation of
an inflammatory state and the formation of IC. In this scenario,
neutrophils migrate to dLNs and promote the activation and
proliferation of CD4+ T cells. At the same time, neutrophils
upregulate PD-L1 to avoid excessive CD4+ T cell proliferation,
resulting in a negative feedback mechanism of CD4+ T cell
response. It would be useful to learn more about the signals
that upregulate PD-L1 in neutrophils, to be able to use that
information for the treatment of clinical diseases. In pathologies
where a large neutrophil infiltrate is produced, it is important not
only to know the pro-inflammatory functions that the neutrophil
may exert, but also to consider it as a cell with the capacity to
modulate the adaptive immune response.
PD-L1+ neutrophils may exert different roles according to the
pathology to which they are associated. The presence of these cells
in tumor bearing hosts has been reported to be detrimental, since
they prevent the tumor cells from being attacked by the adaptive
immunity (48). However, in autoimmune diseases which are
characterized by a great inflammatory state and the presence of
autoantibodies, the expression of PD-L1 by neutrophils might be
an important mechanism for keeping a balance between effective
immunity, tolerance and immunopathology. In line with this,
it has been reported that the frequency of PD-L1-expressing
neutrophils were elevated in patients with systemic lupus
erythematosus (49) and rheumatoid arthritis (50) in correlation
with increased autoimmune antibodies, inflammatory markers,
and severity of the disease. In these systemic autoimmune
diseases, the expression of PD-L1 by neutrophils may function
as a negative feedback mechanism, preventing potential tissue
damage caused by excessive autoimmune responses.
It has been also reported in a model of Sepsis-induced
Immunosuppression an up-regulation of PD-L1 on neutrophils
(51). The correlation of these cells with the severity of the disease
suggests that PD-L1+ neutrophil levels might be a potential
diagnostic biomarker for severe inflammatory diseases.
In conclusion, our study reveals a dual function of neutrophils
present in dLNs in terms of CD4+ T cell modulation. The
arrival of neutrophils into dLNs enhances the activation and
proliferation of CD4+ T cells, but these cells also impair CD4+
T cell proliferation by a PD-L1 dependent mechanism. In our
model, neutrophils seem to be exerting a critical role in the
maintenance of the homeostatic balance between the activation
of lymphocytes in an adaptive immune response and their
regulation in order to avoid exacerbated response.
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